Apellis Pharmaceuticals Inc Capital Reinvestment Ratio
Apellis Pharmaceuticals Inc capital reinvestment ratio. Apellis Pharmaceuticals Inc (APLS) has a Capital Reinvestment Ratio of 0.00x as of September 2025, meaning it reinvests 0% of its operating cash flow ($108.47 Million) in capital expenditures ($148.00K). Check total reinvestment intensity of Apellis Pharmaceuticals Inc to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Apellis Pharmaceuticals Inc (2025–2025)
Capital reinvestment ratio of Apellis Pharmaceuticals Inc from 2025 to 2025. This chart tracks Apellis Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore Apellis Pharmaceuticals Inc annual equity growth to track the company's year-over-year net asset growth rate.
Apellis Pharmaceuticals Inc Capital Reinvestment Ratio by Year (2025–2025)
Apellis Pharmaceuticals Inc capital reinvestment ratio by year from 2025 to 2025. For the full cash flow conversion analysis, see APLS operating cash flow.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.01x | $45.33 Million | $313.00K | — |